XLVState Street® Health Care Select Sector SPDR® ETF
Sector & Thematic ETF · State Street (SPDR)
Holdings as of Aug 6, 2026
XLV is a Sector & Thematic ETF from State Street (SPDR) holding 61 positions as of Aug 6, 2026, with $41.9B in assets and a 0.08% net expense ratio. Its largest positions are LLY (15.9%), JNJ (10.4%) and ABBV (7.3%); the top 10 holdings account for 60.8% of the portfolio. It yields 1.53% on a trailing-12-month basis.
- Issuer
- State Street (SPDR)
- Holdings
- 61
- Net Assets
- $41.9BETF assets as of 2026-08-10
- Expense Ratio
- 0.08%per latest SEC prospectus filing
- TTM Yield
- 1.53%trailing 12-month distributions
Performance
- 1M
- +0.8%
- YTD
- +7.9%
- 1Y
- +30.7%
- 3Y (ann.)
- +9.2%
- 5Y (ann.)
- +6.2%
- 10Y (ann.)
- +10.0%
A $10,000 investment 10 years ago would be worth $26,032 today at the 10Y annualized rate. This is a backward-looking illustration, not a forecast. Project its future growth →
Total returns including dividends as of 2026-08-07. 3Y/5Y/10Y annualized. Past performance does not predict future results.
Sector Breakdown
| Health Care | 99.8% |
|---|---|
| Other Sectors | 0.0% |
Top 25 Holdings
| # | Holding | Weight |
|---|---|---|
| 1 |  LLYEli Lilly & Co. COM | 15.88% |
| 2 |  JNJJohnson & Johnson COM | 10.42% |
| 3 |  ABBVAbbVie Inc. COM | 7.26% |
| 4 |  UNHUnitedHealth Group Inc. COM | 6.18% |
| 5 |  MRKMerck & Co., Inc COM | 5.34% |
| 6 |  AMGNAmgen Inc. COM | 3.68% |
| 7 |  TMOThermo Fisher Scientific Inc COM | 3.63% |
| 8 |  ABTAbbott Laboratories COM | 3.17% |
| 9 |  GILDGilead Sciences Inc. COM | 2.74% |
| 10 |  PFEPfizer Inc. COM | 2.52% |
| 11 |  ISRGIntuitive Surgical Inc. COM NEW | 2.23% |
| 12 |  BMYBristol-Myers Squibb Company COM | 2.21% |
| 13 |  DHRDanaher Corporation COM | 2.12% |
| 14 |  VRTXVertex Pharmaceuticals Incorporated COM | 2.07% |
| 15 |  CVSCVS Health Corp COM | 2.07% |
| 16 |  SYKStryker Corporation COM | 1.96% |
| 17 |  MDTMedtronic PLC USD0.0001 | 1.86% |
| 18 |  MCKMckesson Corp. COM | 1.76% |
| 19 |  ELVElevance Health Inc. COM | 1.43% |
| 20 |  REGNRegeneron Pharmaceuticals, Inc. COM | 1.30% |
| 21 |  BSXBoston Scientific Corporation COM | 1.23% |
| 22 |  CIThe Cigna Group COM | 1.23% |
| 23 |  HCAHCA Healthcare Inc COM | 1.07% |
| 24 |  CORCencora Inc COM | 1.06% |
| 25 |  CAHCardinal Health, Inc. COM | 0.94% |
Showing the top 25 of 61 holdings. See the full XLV holdings list →
XLV alternatives
The closest Sector & Thematic ETFs to XLV by portfolio overlap — the share of weight both funds hold in the same securities.
| Fund | Overlap | Expense | Assets | |
|---|---|---|---|---|
 IYHiShares U.S. Healthcare ETF | 89% | 0.38%pricier | $3.7B | Compare → |
 VHTVanguard Health Care Index Fund | 85% | 0.09%pricier | $18.3B | Compare → |
| 85% | 0.08% | $3.3B | Compare → | |
 RSPHInvesco S&P 500 Equal Weight Health Care ETF | 53% | 0.4%pricier | $776M | Compare → |
 XTiShares Future Exponential Technologies ETF | 16% | 0.46%pricier | $3.9B | Compare → |
 IHIiShares U.S. Medical Devices ETF | 16% | 0.38%pricier | $3.4B | Compare → |
 IBBiShares Biotechnology ETF | 11% | 0.44%pricier | $9.3B | Compare → |
 XBIState Street® SPDR® S&P® Biotech ETF | 7% | 0.35%pricier | $10.0B | Compare → |
Frequently Asked Questions
What is XLV's expense ratio?
XLV has a net expense ratio of 0.08%, per its latest SEC prospectus filing. That works out to about $8 a year on a $10,000 investment.
How many holdings does XLV have?
XLV held 61 positions as of Aug 6, 2026, per its latest official holdings data.
What are XLV's top 10 holdings?
XLV's largest positions are LLY (15.9%), JNJ (10.4%), ABBV (7.3%), UNH (6.2%), MRK (5.3%), AMGN (3.7%), TMO (3.6%), ABT (3.2%), GILD (2.7%), PFE (2.5%). Together they account for 60.8% of the portfolio.
What is XLV's dividend yield?
XLV yields 1.53% based on its trailing 12-month distributions, as of Aug 7, 2026.
How big is XLV?
XLV has $41.9B in assets as of Aug 10, 2026.
What are good alternatives to XLV?
By portfolio overlap, the closest Sector & Thematic ETFs to XLV are IYH (89% overlap), VHT (85% overlap), FHLC (85% overlap). Overlap measures the share of portfolio weight both funds hold in the same securities.